White Line Pharma Profile
Key Indicators
- Authorised Capital ₹ 7.50 M
- Paid Up Capital ₹ 7.50 M
- Company Age 23 Year, 1 Month
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 3.64 Cr
- Satisfied Charges ₹ 3.95 Cr
- Revenue Growth 32.82%
- Profit Growth 41.88%
- Ebitda 16.66%
- Net Worth 9.44%
- Total Assets 11.60%
About White Line Pharma
White Line Pharma Private Limited (WLPPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 21 December 2001 and has a history of 23 years and one month. Its registered office is in Kalpetta, Kerala, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 7.50 M and a paid-up capital of Rs 7.50 M.
The company currently has active open charges totaling ₹3.64 Cr. The company has closed loans amounting to ₹3.95 Cr, as per Ministry of Corporate Affairs (MCA) records.
Kizhakke Sharmil, Cholangady Vinod, and Aramangalam Ramakrishnan serve as directors at the Company.
Company Details
-
Location
Kalpetta, Kerala, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U24231KL2001PTC015134
-
Company No.
015134
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
21 Dec 2001
-
Date of AGM
30 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Ernakulam
Industry
Who are the key members and board of directors at White Line Pharma?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Aramangalam Ramakrishnan
|
Managing Director | 21-Dec-2001 | Current |
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
|
Kizhakke Sharmil
|
Director | 31-Dec-2019 | Current |
|
Cholangady Vinod
|
Director | 21-Dec-2001 | Current |
Financial Performance of White Line Pharma.
White Line Pharma Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 32.82% increase. The company also saw a substantial improvement in profitability, with a 41.88% increase in profit. The company's net worth moved up by a moderate rise of 9.44%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of White Line Pharma?
In 2023, White Line Pharma had a promoter holding of 16.00% and a public holding of 84.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹36.37 M
₹39.50 M
Charges Breakdown by Lending Institutions
- Others : 3.64 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 24 Jan 2022 | Others | ₹2.10 M | Open |
| 10 Jun 2020 | Others | ₹4.27 M | Open |
| 02 Aug 2017 | Others | ₹3.00 Cr | Open |
| 13 Mar 2013 | State Bank Of Travancore | ₹1.95 Cr | Satisfied |
| 17 May 2012 | Vijaya Bank | ₹7.50 M | Satisfied |
How Many Employees Work at White Line Pharma?
Unlock and access historical data on people associated with White Line Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of White Line Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped White Line Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
